Neurotransmitter Actions in CNS and PNS
This set covers the physiological actions and roles of major neurotransmitters in the central and peripheral nervous systems for anatomy students.
Cards · 50
- Acetylcholine (ACh) primary CNS action
- Controls skeletal muscle actions and promotes alertness, memory, and cognitive functioning in the brain.
- Acetylcholine (ACh) primary PNS action
- Stimulates skeletal muscle contraction at neuromuscular junctions; excites or inhibits autonomic effectors.
- Norepinephrine primary CNS action
- Creates a sense of well-being and helps regulate mood, alertness, and wakefulness.
- Norepinephrine primary PNS action
- May excite or inhibit autonomic effectors, notably increasing heart rate and regulating vascular tone.
- Dopamine primary CNS action
- Creates a sense of well-being, coordinates voluntary skeletal muscle movements, and reinforces reward pathways.
- Dopamine primary PNS action
- Acts limitedly in autonomic motor pathways and influences vascular smooth muscle tone and vasodilation.
- Serotonin primary CNS action
- Primarily inhibitory; leads to sleepiness, stabilizes mood, and regulates body temperature and appetite.
- Serotonin primary PNS action
- Regulates gastrointestinal motility and secretion, and stimulates vasoconstriction during blood clotting.
- Histamine primary CNS action
- Promotes alertness, wakefulness, and circadian rhythm maintenance in the hypothalamus.
- Histamine primary PNS action
- Mediates inflammation, triggers vasodilation, increases vascular permeability, and constricts airways.
- GABA (Gamma-aminobutyric acid) primary CNS action
- The major inhibitory neurotransmitter in the brain; reduces neuronal excitability to prevent overstimulation.
- GABA (Gamma-aminobutyric acid) PNS action
- Generally uncommon in the peripheral nervous system, with trace roles in the enteric nervous system.
- Glutamate primary CNS action
- The major excitatory neurotransmitter in the brain and spinal cord, vital for learning and synaptic plasticity.
- Glutamate PNS action
- Modulates peripheral nociceptive signaling and neuromuscular transmission in some autonomic tissues.
- Glycine primary CNS action
- Acts as a primary inhibitory neurotransmitter in the spinal cord and brainstem.
- Glycine PNS action
- Essentially absent as a neurotransmitter in the peripheral nervous system; primarily confined to the CNS.
- Substance P primary CNS action
- Excitatory peptide that transmits pain signals into the spinal cord and higher brain regions.
- Substance P primary PNS action
- Released by sensory neurons to mediate neurogenic inflammation, vasodilation, and local pain reception.
- Endorphins and enkephalins primary CNS action
- Inhibit pain perception in the brain and spinal cord by blocking the release of Substance P.
- Endorphins and enkephalins primary PNS action
- Modulate sensory nerve terminals, reducing pain sensitivity and decreasing gastrointestinal motility.
- Nitric oxide (NO) primary CNS action
- Diffuses through membranes as a gas, acting in memory formation and synaptic plasticity in the brain.
- Nitric oxide (NO) primary PNS action
- Acts as a potent vasodilator and causes relaxation of smooth muscle in vascular walls and the GI tract.
- Epinephrine primary CNS action
- Acts in low concentrations to regulate autonomic functions, stress responses, and thalamic arousal.
- Epinephrine primary PNS action
- Mainly secreted into blood by the adrenal medulla; elevates heart rate, dilates airways, and mobilizes glucose.
- Excitatory postsynaptic potential (EPSP)
- Local depolarization that moves the membrane potential closer to threshold, increasing firing likelihood.
- Inhibitory postsynaptic potential (IPSP)
- Local hyperpolarization that moves the membrane potential farther from threshold, reducing firing likelihood.
- Acetylcholinesterase (AChE) function
- Rapidly decomposes acetylcholine in the synaptic cleft to prevent continuous stimulation of the postsynaptic cell.
- Monoamine oxidase (MAO) function
- Enzymatically degrades monoamines like norepinephrine, epinephrine, and dopamine inside the synaptic knob.
- Reuptake mechanism in monoaminergic synapses
- Transporters actively pump monoamines back into the presynaptic knob to terminate synaptic transmission.
- Neuropeptides synthesis site
- Synthesized in the rough endoplasmic reticulum of the neuron cell body and transported to synaptic knobs.
- Monoamine category classification
- Modified amino acids including dopamine, norepinephrine, epinephrine, serotonin, and histamine.
- Amino acid neurotransmitters classification
- Unmodified amino acids functioning as neurotransmitters, principally GABA, glutamate, and glycine.
- Clinical effect of low CNS dopamine
- Leads to tremors, rigidity, and muscle control loss characteristic of Parkinson disease.
- Clinical effect of low CNS serotonin
- Linked to major depressive disorder, insomnia, and anxiety, frequently targeted by SSRIs.
- Clinical effect of low CNS acetylcholine
- Associated with memory loss, disorientation, and cognitive decline seen in Alzheimer disease.
- Parasympathetic nervous system main neurotransmitter
- Acetylcholine, released by both preganglionic and postganglionic parasympathetic neurons.
- Sympathetic postganglionic main neurotransmitter
- Norepinephrine, released onto adrenergic receptors of visceral effectors (except sweat glands).
- Sympathetic preganglionic main neurotransmitter
- Acetylcholine, which excites nicotinic receptors on postganglionic sympathetic neurons.
- Neuromuscular junction primary neurotransmitter
- Acetylcholine, binding nicotinic receptors on the motor end plate of skeletal muscle fibers.
- Ionotropic versus metabotropic neurotransmitter receptors
- Ionotropic receptors directly open ion channels; metabotropic receptors activate G proteins and second messengers.
- Calcium ion influx role in neurotransmitter release
- Action potential opens voltage-gated Ca2+ channels, causing vesicle exocytosis into the cleft.
- Purinergic neurotransmitter: Adenosine role
- Inhibits CNS arousal, promotes sleepiness, and modulates vascular tone in peripheral tissues.
- Purinergic neurotransmitter: ATP role
- Acts as an excitatory co-transmitter with norepinephrine or ACh, modulating smooth muscle contraction.
- Cholecystokinin (CCK) neuropeptide role
- Signals satiety and modulates anxiety in the CNS; stimulates pancreatic secretion and gall bladder in the PNS.
- Neuropeptide Y (NPY) role
- Stimulates appetite and food intake in the CNS; causes vasoconstriction in peripheral vascular smooth muscle.
- Endocannabinoid mechanism of action
- Retrograde lipid messengers that travel back to presynaptic receptors to inhibit neurotransmitter release.
- Strychnine toxicity mechanism on glycine
- Blocks inhibitory glycine receptors in the spinal cord, leading to uncontrollable and fatal muscle spasms.
- Tetanus toxin effect on neurotransmitters
- Prevents the presynaptic release of inhibitory GABA and glycine, causing rigid spastic paralysis.
- Botulinum toxin effect on acetylcholine
- Inhibits acetylcholine release at the neuromuscular junction, causing flaccid skeletal muscle paralysis.
- Spatial versus temporal summation of neurotransmitters
- Spatial summation combines inputs from multiple knobs; temporal summation combines rapid inputs from one knob.